Evidence Synthesis
Hester Bio experienced a significant acceleration in its gross margin, increasing to 74.86% from 20.37% in the previous quarter.
This represents a quarterly growth rate of 2.68%. In contrast, the company's marginal operating leverage declined to , down from 41.61% in the previous quarter. Additionally, Hester Bio's revenue growth year-over-year declined to -8.2%, a decrease from 459.3% in the previous quarter. The company's daily volume decreased to 5,502 shares, a decline of 0.77 shares from the previous day. Furthermore, the close price decreased to 2,367.8 INR, a drop of 0.018 INR from the previous day.